As on Wednesday, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) got off with the flyer as it spiked 0.69% to $13.18, before settling in for the price of $13.09 at the close. Taking a more long-term approach, TEVA posted a 52-week range of $7.09-$14.47.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of -2.68% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 26.63%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -6.18%. This publicly-traded company’s shares outstanding now amounts to $1.12 billion, simultaneously with a float of $1.12 billion. The organization now has a market capitalization sitting at $14.77 billion. At the time of writing, stock’s 50-day Moving Average stood at $13.41, while the 200-day Moving Average is $10.61.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – Specialty & Generic industry. Teva- Pharmaceutical Industries Ltd. ADR’s current insider ownership accounts for 0.01%, in contrast to 52.44% institutional ownership. According to the most recent insider trade that took place on Mar 06 ’24, this organization’s EVP, Chief Financial Officer sold 77,550 shares at the rate of 13.52, making the entire transaction reach 1,048,119 in total value, affecting insider ownership by 203,691. Preceding that transaction, on Mar 05 ’24, Company’s EVP, International Markets sold 100,000 for 13.52, making the whole transaction’s value amount to 1,352,090. This particular insider is now the holder of 382,590 in total.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.98 per share during the current fiscal year.
Teva- Pharmaceutical Industries Ltd. ADR’s EPS decrease for this current 12-month fiscal period is -6.18% and is forecasted to reach 2.63 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 1.60% through the next 5 years, which can be compared against the 26.63% growth it accomplished over the previous five years trading on the market.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Trading Performance Indicators
Let’s observe the current performance indicators for Teva- Pharmaceutical Industries Ltd. ADR (TEVA). It’s Quick Ratio in the last reported quarter now stands at 0.69. The Stock has managed to achieve an average true range (ATR) of 0.36. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.93. Similarly, its price to free cash flow for trailing twelve months is now 6.37.
In the same vein, TEVA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.48, a figure that is expected to reach 0.52 in the next quarter, and analysts are predicting that it will be 2.63 at the market close of one year from today.
Technical Analysis of Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
Through scrutinizing the latest numbers posted by the [Teva- Pharmaceutical Industries Ltd. ADR, TEVA], it can be observed that its last 5-days Average volume of 10.6 million was lower the volume of 10.71 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 8.83% While, its Average True Range was 0.36.
Raw Stochastic average of Teva- Pharmaceutical Industries Ltd. ADR (TEVA) in the period of the previous 100 days is set at 74.88%, which indicates a major rise in contrast to 12.88% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 24.70% that was lower than 29.80% volatility it exhibited in the past 100-days period.
